183 related articles for article (PubMed ID: 26745629)
21. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA
J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159
[TBL] [Abstract][Full Text] [Related]
22. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
23. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive investigation regarding the clinical significance of ITGB4 in oral squamous cell carcinoma combining immunohistochemistry, RNA-seq, and microarray data.
Wang XM; Chen G; Dang YW; Li J; Li P; Li ZY
Comput Biol Chem; 2023 Jun; 104():107846. PubMed ID: 36934520
[TBL] [Abstract][Full Text] [Related]
25. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
Liu YM; Huang JH; Feng DY; Guo XC
Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
27. [Expression of galectin-1 in carcinogenesis of oral mucosal epithelium].
Wei KJ; Pan HY; Yang X; Zhong LP; Ye DX; Zhang ZY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Sep; 46(9):524-7. PubMed ID: 22177353
[TBL] [Abstract][Full Text] [Related]
28. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
29. Gene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes.
Lohavanichbutr P; Houck J; Doody DR; Wang P; Mendez E; Futran N; Upton MP; Holsinger FC; Schwartz SM; Chen C
PLoS One; 2012; 7(9):e46575. PubMed ID: 23029552
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
32. [Preliminary study on the role of voltage-gated sodium channel subtype Nav1.5 in lymph node metastasis of oral squamous cell carcinoma].
Liu WJ; Xu L; Zhu XW; Chen XF; Wang H; Jiang Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Mar; 52(3):188-193. PubMed ID: 28279058
[No Abstract] [Full Text] [Related]
33. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
34. Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade.
Doll C; Arsenic R; Lage H; Jöhrens K; Hartwig S; Nelson K; Raguse JD
Anticancer Res; 2015 Nov; 35(11):5867-72. PubMed ID: 26504009
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma.
Kamatani T; Shiogama S; Yoshihama Y; Kondo S; Shirota T; Shintani S
Cytokine; 2013 Nov; 64(2):497-502. PubMed ID: 24063998
[TBL] [Abstract][Full Text] [Related]
36. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma.
Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS
J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of metastasis of oral squamous cell carcinoma by anti-PLGF treatment.
Bu J; Bu X; Liu B; Chen F; Chen P
Tumour Biol; 2015 Apr; 36(4):2695-701. PubMed ID: 25432135
[TBL] [Abstract][Full Text] [Related]
38. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7.
Jung DW; Che ZM; Kim J; Kim K; Kim KY; Williams D; Kim J
Int J Cancer; 2010 Jul; 127(2):332-44. PubMed ID: 19937793
[TBL] [Abstract][Full Text] [Related]
39. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
Yue ZW; Liu JZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
[No Abstract] [Full Text] [Related]
40. Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.
Cetindis M; Biegner T; Munz A; Teriete P; Reinert S; Grimm M
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):495-503. PubMed ID: 25663193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]